Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty Pharma. Royalty Pharma plc (Nasdaq: RPRX) has entered into an agreement with Biogen to provide...
Royalty Pharma’s Agreement with Biogen
MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...
Royalty Pharmaìs Acquisition of Royalty Interest from GSK
Dechert advised Royalty Pharma on the deal. Royalty Pharma plc executed its acquisition of a royalty interest in the cabozantinib products Cabometyx and Cometriq from GlaxoSmithKline...